Understanding the Genetic
Architecture of Parkinson's Disease
The Global Parkinson’s Genetics Program (GP2) is an ambitious program to genotype >150,000 volunteers around the world to further understand the genetic architecture of Parkinson’s disease (PD). There is still much to learn about genetic risk factors and the path to further understanding requires working collaboratively and openly sharing data, processes, and results.
See how many samples are completed and shared with the AMP® PD platform for use.
Submit a Cohort
Collaborate with us and submit a cohort to GP2.
Check out the latest news about GP2.
Additional Funding Furthers Efforts to Understand the Genetic Architecture of Parkinson’s Disease
March 31, 2023
We’re pleased to share that GP2’s funding has been extended for another five years. This extension allows for an expanded focus on underrepresented populations while also providing the opportunity to extend research into the very early stages of PD and to Parkinson’s spectrum disorders.
GP2 Cohort Dashboard Now Includes New Ancestry Categories
December 9, 2022
The updated GP2 Cohort dashboard now includes additional ancestry information across cohort samples that have already been processed and shared with the AMP PD platform.
Latest Blog Posts
Read the latest blogs from GP2’s scientists and collaborators.
The Components of GP2’s Fifth Data Release
May 9, 2023
This release includes 7,462 additional new complex disease participants and 487 new monogenic disease participants, adding to the previous releases from the Complex and Monogenic Networks.
GP2 Visits India
May 8, 2023
GP2 recently visited India where study team members took advantage of the 8th Asian and Oceanian Parkinson’s Disease and Movement Disorders Congress (AOPMC) held in Kolkata, along with a few select site visits, to build more meaningful interactions with GP2 collaborators and trainees from the region.
Precision Medicine in Parkinson's Disease: Past Lessons and New Frontiers
April 4, 2023
Members of the GP2 Trainee Network recently had the opportunity to attend a two-day conference called ‘Precision Medicine in Parkinson's Disease: past lessons and conquering new frontiers’. The conference centered on work to increase our understanding of Parkinson’s disease (PD) and related disorders around the world.
Find out about GP2’s working groups and their recently accomplished milestones.